EXELAN PHARMACEUTICALS INC
- BOCA RATON, FL 33432-5826
- exelanpharma.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $175.2M
- Awards on record
- 95
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
EXELAN PHARMACEUTICALS INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About EXELAN PHARMACEUTICALS INC
- Headquarters
- BOCA RATON, FL 33432-5826
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIFYZXNHSQTMG8
- CAGE6GFC4
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $175.2M
- Awards on record
- 95
- Top funding agencies
- Department of Veterans Affairs · Office of Assistant Secretary for Preparedness and Response · Federal Prison System / Bureau of Prisons
25 most recent of 95 awards
36C24226N0564
Recompete 18+ mo: Potential end May 31, 2029 (30 months away)LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $3.1M
- Period of performance
- Jun 1, 2026 – May 31, 2029
36C25226P0148
Recompete 12–18 mo: Potential end Nov 15, 2027 (12 months away)LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $3.3M
- Period of performance
- Jan 16, 2026 – Nov 15, 2027
15B30326F00000035
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)FLU VACCINE FOR INMATES 65 AND OLDER
Department of Justice · Federal Prison System / Bureau of Prisons
- Obligated
- $1.7K
- Period of performance
- Oct 1, 2026 – Sep 30, 2027
36C24827N0053
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $2.5M
- Period of performance
- Oct 1, 2026 – Sep 30, 2027
36C26027F0002
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)LENALIDOMIDE 2.5MG - 25MG
Department of Veterans Affairs
- Obligated
- $1.5M
- Period of performance
- Oct 1, 2026 – Sep 30, 2027
36C26027F0007
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)BULK LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $789.6K
- Period of performance
- Oct 1, 2026 – Sep 30, 2027
75A50325F80014
Recompete 6–12 mo: Potential end Jun 29, 2027 (7 months away)OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 76282-0704-45); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC:…
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $74.1M
- Period of performance
- Jun 28, 2025 – Jun 29, 2027
36C26026F0261
Recompete 6–12 mo: Potential end May 31, 2027 (6 months away)LENALIDOMIDE 5MG CAP,ORAL
Department of Veterans Affairs
- Obligated
- $918.8K
- Period of performance
- Jun 1, 2026 – May 31, 2027
36C25926F0197
Recompete 6–12 mo: Potential end May 17, 2027 (6 months away)LENALIDOMIDE RX
Department of Veterans Affairs
- Obligated
- $1.8M
- Period of performance
- May 18, 2026 – May 17, 2027
36C24426N0398
Recompete < 6 mo: Potential end Feb 5, 2027 (2 months away)SPECIALTY PHARMACEUTICAL LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $136.7K
- Period of performance
- Feb 6, 2026 – Feb 5, 2027
36C24426N0404
Recompete < 6 mo: Potential end Feb 5, 2027 (2 months away)SPECIALTY PHARMACEUTICALS LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $476.3K
- Period of performance
- Feb 6, 2026 – Feb 5, 2027
36C25726N0241
Recompete < 6 mo: Potential end Feb 5, 2027 (2 months away)LENALIDOMIDE ORAL MED
Department of Veterans Affairs
- Obligated
- $899.3K
- Period of performance
- Feb 6, 2026 – Feb 5, 2027
36C26026F0144
Recompete < 6 mo: Potential end Jan 18, 2027 (2 months away)LENALIDOMIDE - ONCOLOGY TREATMENT FOR VETERANS DIFFERENT MILLIGRAMS.
Department of Veterans Affairs
- Obligated
- $470.1K
- Period of performance
- Jan 19, 2026 – Jan 18, 2027
36C25226P0149
Recompete < 6 mo: Potential end Jan 15, 2027 (2 months away)LENALIDOMIDE
Department of Veterans Affairs
- Obligated
- $1.8M
- Period of performance
- Jan 16, 2026 – Jan 15, 2027
36C26026F0124
Recompete < 6 mo: Potential end Jan 15, 2027 (2 months away)LENALIDOMIDE CAPSULES.
Department of Veterans Affairs
- Obligated
- $2.5M
- Period of performance
- Jan 16, 2026 – Jan 15, 2027
36C26227N0055
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)VASD LENALIDOMIDE FY27 DO
Department of Veterans Affairs
- Obligated
- $750K
- Period of performance
- Oct 16, 2026 – Jan 14, 2027
36C24626N0406
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)LENALIDOMIDE FOR THE HAMPTON VAMC FOR PATIENT CARE.
Department of Veterans Affairs
- Obligated
- $1.6M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C24626N0410
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
Department of Veterans Affairs
- Obligated
- $5.1M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C24626N0413
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)LENALIDOMIDE FOR THE ASHEVILLE VAMC FOR PATIENT CARE.
Department of Veterans Affairs
- Obligated
- $3M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C24626N0416
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)LENALIDOMIDE FOR THE DURHAM VAMC FOR PATIENT CARE
Department of Veterans Affairs
- Obligated
- $4.5M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C24626N0420
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)LENALIDOMIDE FOR THE RICHMOND VAMC FOR PATIENT CARE
Department of Veterans Affairs
- Obligated
- $4.1M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C24626N0421
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)LENOLIDAMIDE FOR THE SALEM VAMC FOR PATIENT CARE
Department of Veterans Affairs
- Obligated
- $1.2M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C24626N0422
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)LENALIDOMIDE FOR FAYETTEVILLE VAMC PATIENT CARE
Department of Veterans Affairs
- Obligated
- $3.5M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C26226N0305
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)VA ALBUQUERQUE LENALIDOMIDE DO
Department of Veterans Affairs
- Obligated
- $2.1M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C26226N0306
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)VA LONG BEACH LENALIDOMIDE DO
Department of Veterans Affairs
- Obligated
- $1.1M
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C24226N0564 under 36F79720D0227 LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.1M | Jun 1, 2026 – May 31, 2029 | Recompete 18+ mo: Potential end May 31, 2029 (30 months away) |
36C25226P0148 LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.3M | Jan 16, 2026 – Nov 15, 2027 | Recompete 12–18 mo: Potential end Nov 15, 2027 (12 months away)AI brief for award 36C25226P0148Bid team for the recompete of award 36C25226P0148 |
15B30326F00000035 under 36E79722D0010 FLU VACCINE FOR INMATES 65 AND OLDER | Department of Justice · Federal Prison System / Bureau of Prisons | 325412 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $1.7K | Oct 1, 2026 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 15B30326F00000035Bid team for the recompete of award 15B30326F00000035 |
36C24827N0053 under 36F79720D0227 LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $2.5M | Oct 1, 2026 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C24827N0053Bid team for the recompete of award 36C24827N0053 |
36C26027F0002 under 36F79720D0227 LENALIDOMIDE 2.5MG - 25MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.5M | Oct 1, 2026 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C26027F0002Bid team for the recompete of award 36C26027F0002 |
36C26027F0007 under 36F79720D0227 BULK LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $789.6K | Oct 1, 2026 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C26027F0007Bid team for the recompete of award 36C26027F0007 |
75A50325F80014 under 36F79720D0227 OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 76282-0704-45); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC:… | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325412 · 6505DRUGS AND BIOLOGICALS | $74.1M | Jun 28, 2025 – Jun 29, 2027 | Recompete 6–12 mo: Potential end Jun 29, 2027 (7 months away)AI brief for award 75A50325F80014Bid team for the recompete of award 75A50325F80014 |
36C26026F0261 under 36F79720D0227 LENALIDOMIDE 5MG CAP,ORAL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $918.8K | Jun 1, 2026 – May 31, 2027 | Recompete 6–12 mo: Potential end May 31, 2027 (6 months away)AI brief for award 36C26026F0261Bid team for the recompete of award 36C26026F0261 |
36C25926F0197 under 36F79720D0227 LENALIDOMIDE RX | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.8M | May 18, 2026 – May 17, 2027 | Recompete 6–12 mo: Potential end May 17, 2027 (6 months away)AI brief for award 36C25926F0197Bid team for the recompete of award 36C25926F0197 |
36C24426N0398 under 36F79720D0227 SPECIALTY PHARMACEUTICAL LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $136.7K | Feb 6, 2026 – Feb 5, 2027 | Recompete < 6 mo: Potential end Feb 5, 2027 (2 months away)AI brief for award 36C24426N0398Bid team for the recompete of award 36C24426N0398 |
36C24426N0404 under 36F79720D0227 SPECIALTY PHARMACEUTICALS LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $476.3K | Feb 6, 2026 – Feb 5, 2027 | Recompete < 6 mo: Potential end Feb 5, 2027 (2 months away)AI brief for award 36C24426N0404Bid team for the recompete of award 36C24426N0404 |
36C25726N0241 under 36F79720D0227 LENALIDOMIDE ORAL MED | Department of Veterans Affairs | 325412 · Q509FAMILY & INTERNAL MEDICINE SERVICES | $899.3K | Feb 6, 2026 – Feb 5, 2027 | Recompete < 6 mo: Potential end Feb 5, 2027 (2 months away)AI brief for award 36C25726N0241Bid team for the recompete of award 36C25726N0241 |
36C26026F0144 under 36F79720D0227 LENALIDOMIDE - ONCOLOGY TREATMENT FOR VETERANS DIFFERENT MILLIGRAMS. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $470.1K | Jan 19, 2026 – Jan 18, 2027 | Recompete < 6 mo: Potential end Jan 18, 2027 (2 months away)AI brief for award 36C26026F0144Bid team for the recompete of award 36C26026F0144 |
36C25226P0149 LENALIDOMIDE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.8M | Jan 16, 2026 – Jan 15, 2027 | Recompete < 6 mo: Potential end Jan 15, 2027 (2 months away)AI brief for award 36C25226P0149Bid team for the recompete of award 36C25226P0149 |
36C26026F0124 under 36F79720D0227 LENALIDOMIDE CAPSULES. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $2.5M | Jan 16, 2026 – Jan 15, 2027 | Recompete < 6 mo: Potential end Jan 15, 2027 (2 months away)AI brief for award 36C26026F0124Bid team for the recompete of award 36C26026F0124 |
36C26227N0055 under 36C26226A0006 VASD LENALIDOMIDE FY27 DO | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $750K | Oct 16, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C26227N0055Bid team for the recompete of award 36C26227N0055 |
36C24626N0406 under 36F79720D0227 LENALIDOMIDE FOR THE HAMPTON VAMC FOR PATIENT CARE. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.6M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C24626N0406Bid team for the recompete of award 36C24626N0406 |
36C24626N0410 under 36F79720D0227 LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $5.1M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C24626N0410Bid team for the recompete of award 36C24626N0410 |
36C24626N0413 under 36F79720D0227 LENALIDOMIDE FOR THE ASHEVILLE VAMC FOR PATIENT CARE. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C24626N0413Bid team for the recompete of award 36C24626N0413 |
36C24626N0416 under 36F79720D0227 LENALIDOMIDE FOR THE DURHAM VAMC FOR PATIENT CARE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $4.5M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C24626N0416Bid team for the recompete of award 36C24626N0416 |
36C24626N0420 under 36F79720D0227 LENALIDOMIDE FOR THE RICHMOND VAMC FOR PATIENT CARE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $4.1M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C24626N0420Bid team for the recompete of award 36C24626N0420 |
36C24626N0421 under 36F79720D0227 LENOLIDAMIDE FOR THE SALEM VAMC FOR PATIENT CARE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.2M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C24626N0421Bid team for the recompete of award 36C24626N0421 |
36C24626N0422 under 36F79720D0227 LENALIDOMIDE FOR FAYETTEVILLE VAMC PATIENT CARE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.5M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C24626N0422Bid team for the recompete of award 36C24626N0422 |
36C26226N0305 under 36C26226A0006 VA ALBUQUERQUE LENALIDOMIDE DO | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $2.1M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C26226N0305Bid team for the recompete of award 36C26226N0305 |
36C26226N0306 under 36C26226A0006 VA LONG BEACH LENALIDOMIDE DO | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.1M | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award 36C26226N0306Bid team for the recompete of award 36C26226N0306 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with EXELAN PHARMACEUTICALS INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
